T, S., KC, M., D, L., A, W., F, H., MS, C., . . . AA, C. (2010). Efficacy of lenalidomide in patients with chronic lymphocytic leukemia with high-risk cytogenetics. Leukemia & lymphoma, 51(1), 85. https://doi.org/10.3109/10428190903406806
Chicago Style (17th ed.) CitationT, Sher, et al. "Efficacy of Lenalidomide in Patients with Chronic Lymphocytic Leukemia with High-risk Cytogenetics." Leukemia & Lymphoma 51, no. 1 (2010): 85. https://doi.org/10.3109/10428190903406806.
MLA (9th ed.) CitationT, Sher, et al. "Efficacy of Lenalidomide in Patients with Chronic Lymphocytic Leukemia with High-risk Cytogenetics." Leukemia & Lymphoma, vol. 51, no. 1, 2010, p. 85, https://doi.org/10.3109/10428190903406806.
Warning: These citations may not always be 100% accurate.